f Recent Advances in the Medicinal Chemistry of Cancer (Part II)

References

1. KadryM.O. Abd-EllatefG.E.F. AmmarN.M. HassanH.A. HusseinN.S. KamelN.N. SoltanM.M. Abdel-MegeedR.M. Abdel-HamidA.Z. Metabolomics integrated genomics approach: Understanding multidrug resistance phenotype in MCF-7 breast cancer cells exposed to doxorubicin and ABCA1/EGFR/PI3k/PTEN crosstalk.Toxicol. Rep.20241410110110.1016/j.toxrep.2024.101
   [Google Scholar]
2. Dagogo-JackI. ShawA.T. Tumour heterogeneity and resistance to cancer therapies.Nat. Rev. Clin. Oncol.2018152819410.1038/nrclinonc.2017.166 29115304
   [Google Scholar]
3. SarkarB. ChakrabortyS. RakshitG. SinghR.P. Fundamental approaches of drug discovery.In: Biochemical and Molecular Pharmacology in Drug Discovery.Elsevier202425128210.1016/B978‑0‑443‑16013‑4.00012‑9
   [Google Scholar]
4. SarkarK. DebnathS. SenD. KarS. SilS.K. Crucial structural understanding for selective HDAC8 inhibition: common pharmacophores, molecular docking, molecular dynamics, and zinc binder analysis of selective HDAC8 inhibitors.Med. Chem.2024217 39039678
   [Google Scholar]
5. KostovaI. Recent advances in anticancer research of osmium and rhodium complexes.Med. Chem.202521710.2174/0115734064327558240826050650
   [Google Scholar]
6. GadoS. HassanM.A-K. KislaM.M. Ates-AlagozZ. Heterocyclic compounds as Bcr-Abl tyrosine kinase inhibitors against chronic myeloid leukemia.Med. Chem.202521710.2174/0115734064311341240929175508
   [Google Scholar]
7. KhatirZ.Z. ValipourM. RahmaniK. AghajanshakeriS. ShokrzadehM. IrannejadH. GhasemianM. Design and development of [1,2,4]triazolo[4,3-b][1,2,4]triazines as potential anticancer agents with genotoxicity and apoptotic activity.Med. Chem.2025217
   [Google Scholar]
8. SroorF.M. YounisE.A. AlyH.F. A preclinical study on 4-Methyl-N-((4-(trifluoromethoxy)phenyl)carbamoyl)-benzenesulfonamide as a potent chemotherapeutic agent againstliver and pancreatic carcinogenesis in rats: immunohistochemical and histopathological studies.Med. Chem.202521710.2174/0115734064308484240820080153
   [Google Scholar]
9. MesciS. AyarA. YazganB. GulM. YıldırımT. Examination of triazolinedione-derived dihydropyrrole hybrid compounds: ER stress-related apoptosis in breast cancer cells, molecular docking, and admet analysis.Med. Chem.202521710.2174/0115734064328727240911112815
   [Google Scholar]
10. FatimaF. NemaP. GarhwalA. KashawS.K. Exploring structural requirement of curcumin-based CK2 inhibitors as anticancer agents: 3D-QSAR, pharmacophore modeling, virtual screening, and molecular docking.Med. Chem.202521739917934
    [Google Scholar]